APLS icon

Apellis Pharmaceuticals

254 hedge funds and large institutions have $4.34B invested in Apellis Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 46 funds opening new positions, 126 increasing their positions, 64 reducing their positions, and 106 closing their positions.

Holders
254
Holders Change
-62
Holders Change %
-19.62%
% of All Funds
4.05%
Holding in Top 10
10
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-33.33%
% of All Funds
0.16%
New
46
Increased
126
Reduced
64
Closed
106
Calls
$373M
Puts
$139M
Net Calls
+$235M
Net Calls Change
+$171M
Name Market Value Shares Shares
Change
Shares
Change %
KFP
351
KB Financial Partners
New Jersey
-192 Closed
Toronto Dominion Bank
352
Toronto Dominion Bank
Ontario, Canada
-119 Closed
FGAM
353
Financial Gravity Asset Management
Texas
-91 Closed
HMS
354
Hanseatic Management Services
New Mexico
-85 Closed
OLVIG
355
Oliver Lagore Vanvalin Investment Group
Michigan
-26 Closed
VCM
356
Versant Capital Management
Arizona
-14 Closed
SWM
357
Spire Wealth Management
Virginia
-12 Closed
CAL
358
Capital Advisors Ltd
Ohio
-8 Closed
BTI
359
Blue Trust Inc
Georgia
-4 Closed
HT
360
HAP Trading
New York
FIA
361
FNY Investment Advisers
New York
MCM
362
Moore Capital Management
New York
Nomura Asset Management
363
Nomura Asset Management
Japan
Twin Tree Management
364
Twin Tree Management
Texas
SSG
365
Summit Securities Group
New York
WVP
366
Worth Venture Partners
New Jersey
Capital Fund Management (CFM)
367
Capital Fund Management (CFM)
France
IMC Chicago
368
IMC Chicago
Illinois
GPP
369
Great Point Partners
Connecticut
UOC
370
UBS O'Connor
Illinois
Parallax Volatility Advisers
371
Parallax Volatility Advisers
California
ACM
372
Altium Capital Management
New York
SFG
373
Steward Financial Group
Texas
$0 4 +4 New